Last Updated on September 3, 2023 by The Health Master
Gujarat FDCA: cancellation of licenses
Gujarat FDCA: The Gujarat Food and Drug Control Administration (FDCA) recently took action against pharmaceutical companies that failed to adhere to Good Manufacturing Practices (GMP) and quality standards.
In a series of risk-based inspections conducted on five companies, licenses of two pharma companies were cancelled due to non-compliance.
Additionally, the license of one section of another company was also revoked, as their products were found to be unstable and exhibited multiple failures during quality testing and analysis.
Reasons for License Cancellation:
This decision was made in the interest of public health and to ensure the quality and safety of pharmaceutical products.
Previous License Cancellations:
These inspections revealed that certain companies were manufacturing substandard quality products, including widely prescribed gastrointestinal medicines, vitamins, oral rehydration salts (ORS), as well as medications like azithromycin for cold, amoxicillin for bacterial infections, and antimalarial medicines.
Pan-India Risk-Based Inspections:
Risk-based inspections are being conducted across India to address the issue of NSQ medicines.
In December of last year, the Central Drugs Standard Control Organization (CDSCO) planned massive risk-based inspections nationwide following the World Health Organization‘s (WHO) call to hold Indian pharma companies accountable for exporting contaminated medicines.
Scope of Inspections and Show Cause Notices:
Over the past six months, a joint team comprising state and central licensing authorities inspected a total of 76 pharma companies across 20 states and union territories.
Out of these, 18 Indian pharma companies had their licenses cancelled based on the risk-based inspections.
The CDSCO identified approximately 203 pharma companies, and more than 25 of them received show cause notices.
Risk-Based Inspection Criteria and Compliance:
These inspections involve evaluating compliance in areas such as sanitation, hygiene, self-inspection, quality audits, prevention of cross-contamination, and bacterial contamination during production.
Both the state drug licensing authorities and the Drugs Controller General of India (DCGI) collaborate to ensure manufacturer compliance with these critical standards.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: